Abstract
The effects of P and six synthetic steroids (MPA, ENT, CAP, R2323, DL and EEL) on estradiol dehydrogenase (E2DH) activity were studied in normal human uterine endometrium in vitro. The mean value of E2DH activity in the proliferative endometrium was 1.5 ± 0.2 nmol/mg protein/h and that in the secretory endometrium was 10.2 ± 1.1 nmol/mg protein/h. There was a 7-fold increase in the secretory phase. E2DH activity in the uterine endometrium was stable during the culture period of up to 72 h. In the proliferative endometrium, P, MPA and ENT (~10−6M) induced E2DH activity during a 24-h incubation. CAP and R2323 had no significant effect. EEL and DL had negligible effects. In contrast, E2DH activity in the secretory endometrium was not induced further by the steroids. Therefore, in the proliferative endometrium, the elevation of E2DH activity is attributable to the progestational activity and, in the secretory endometrium, E2DH activity is not increased further by the progestational agents because it has been already activated fully by P.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Sweat M.L., Young R.B. Low magnitude transformation of estradiol to estrone in human endometrium. Biochim. Biophys. Acta 296: 189, 1973.
Pollow K., Lübbert H., Jeske R., Pollow B. Studies on 17β-hydroxysteroid dehydrogenase in human endometrium and endometrial carcinoma. II. Characterization of the soluble enzyme from secretory endometrium. Acta Endocrinol. (Copenh.) 79: 146, 1975.
Kitawaki J. Studies on estradiol dehydrogenase activity in human uterine endometrium. Folia Endocrinol. Jpn. 63: 894, 1987.
Tseng L., Gurpide E. Estradiol and 20α-dihydroprogesterone dehydrogenase activities in human endometrium during the menstrual cycle. Endocrinology 94: 419, 1974.
Buirchell B.J., Hähnel R. Metabolism of estradiol-17β in human endometrium during the menstrual cycle. J. Steroid Biochem. 6: 1489, 1975.
Gurpide E., Tseng L., Gusberg S.B. Estrogen metabolism in normal and neoplastic endometrium. Am. J. Obstet. Gynecol. 129: 809, 1977.
King R.J.B., Townsend P.T., Whitehead M.I. The role of estradiol dehydrogenase in mediating progestin effects on endometrium from postmenopausal women receiving estrogens and progestins. J. Steroid Biochem. 14: 235, 1981.
Tseng L., Gurpide E. Induction of human endometrial estradiol dehydrogenase by progestins. Endocrinology 97: 825, 1975.
Smith D.C., Prentice R., Thompson D.J., Herrmann W.L. Association of exogenous estrogen and endometrial carcinoma. N. Engl. J. Med. 293: 1164, 1975.
Ziel H.K., Finkle W.D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N.Engl. J.Med. 293: 1167, 1975.
Mack T.M., Pike M.C., Henderson B.E., Pfeffer R.I., Gerkins V.R., Arthur M., Brown S.E. Estrogens and endometrial cancer in a retirement community. N. Engl. J. Med. 294: 1262, 1976.
Gambreil R.D. The prevention of endometrial cancer in postmenopausal women with progestogens. Maturitas 1: 107, 1978.
Whitehead M.I. The effects of oestrogens and progestogens on the postmenopausal endometrium. Maturitas 1: 87, 1978.
Thom M.H., White P.J., Sturdee D.W., Paterson M.E.L., Wade-Evans T., Studd J.W.W. Prevention and treatment of endometrial disease in climacteric women receiving oestrogen therapy. Lancet 2: 455, 1979.
Anderson D.G. Management of advanced endometrial adenocarcinoma with medroxyprogesterone acetate. Am. J. Obstet. Gynecol. 92: 87, 1965.
Kauppila A., Vierikko P., IsotaloH., Rönnberg L., Vihko R. Cytosol estrogen and progestin receptor concentrations and 17β-hydroxysteroid dehydrogenase effects of hormonal treatment. Acta Obstet. Gynecol. Scand. (Suppl.) 123: 45, 1984.
Vierikko P., Kauppila A., Rönnberg L., Vihko R. Steroidal regulation of endometriosis tissue: lack of induction of 17β-hydroxysteroid dehydrogenase activity by progesterone, medroxyprogesterone acetate, or danazol. Fertil. Steril. 43: 218, 1985.
Tseng L., Gusberg S.B., Gurpide E. Estradiol receptor and 17β-dehydrogenase in normal and abnormal human endometrium. Ann. N.Y. Acad. Sci. 286: 190, 1977.
Tseng L. Steroid specificity in the stimulation of human endometrial estradiol dehydrogenase. Endocrinology 102: 1398, 1978.
Okada H., Nawa M., Kimura J. In vitro effect of estrogens on the peroxidase activity of human endometrium. J. Clin. Endocrinol. Metab. 61: 404, 1985.
Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantity of protein utilizing the principle of protein dye binding. Analyt. Biochem. 72: 248, 1976.
Okada H., Honjo H., Ohno Y., Yasuda J. Receptors of synthetic steroid. In: Imura H., Kuzuya H. (Eds.), Proceedings of the International Symposium on Hormone Receptor Disease. Excerpta Medica, Amsterdam, 1983, p. 145.
Clauberg C. Zue Physiologie und Pathologie der Sexualhormone, im bensoderen des Hormons des Curpus luteum. I. Mitteilung: Der biologische test für das Luteohormon (das spezifische Hormon des Corpus luteum) am infantilen Kaninchen. Zbl. Gynäk. 54: 2757, 1930.
Azadian-Boulanger G., Secci J., Sakiz E. Biological study of the anti-progesterone effect of R-2323. Proceedings of the 7th World Congress: Excerpta Medica, Amsterdam, 1971, p. 129.
Sakiz E., Azadian-Boulanger G., Raynaud J.P. Antiestrogens, antiprogesterones. Proceesings of the Fourth International Congress of Endocrinology, Excerpta Medica, Amsterdam, 1972, p. 988.
Author information
Authors and Affiliations
Additional information
The following trivial names and abbreviations were used in this paper: P =progesterone =-pregnen-3, 20-dione; MPA = medroxyprogesterone acetate =6α-methyl-4-pregnen-17α-ol-3, 20-dione acetate; ENT = norethindrone = 17α-ethinyl-4-estren-17β-ol-3-one; CAP = Chlormadinone acetate = 6-chloro-4, 6-pregnadien-17α-ol-3,20-dione acetate; R2323 = 13β-ethyl-17α-ethinyl-4,9,11-gonatrien-17β-ol-3-one; DL = danazol = 17α-ethinyl-2,4-androstadien-(2,4-d)-isoxazol-17α-ol; EEL = lynestrenol = 17α-ethinyl-4-estren-17β-ol; E2 = estradiol-17β = 1,3,5(10)-estratrien-3,17β-diol; E1 = estrone = 1,3,5 (10)-estratrien-3-ol-17-one.
Rights and permissions
About this article
Cite this article
Kitawaki, J., Yamamoto, T. & Okada, H. Induction of estradiol dehydrogenase activity in human uterine endometrium by synthetic steroids. J Endocrinol Invest 11, 351–354 (1988). https://doi.org/10.1007/BF03349053
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03349053